Biomarkers in Risk Assessment: Validity and Validation (Environmental Health Criteria Series) - Ipcs - Livres - World Health Organization - 9789241572224 - 2001
Si la couverture et le titre ne correspondent pas, le titre est correct.

Biomarkers in Risk Assessment: Validity and Validation (Environmental Health Criteria Series)

Ipcs

Prix
SEK 499

Commandé depuis un entrepôt distant

Livraison prévue 16 - 28 oct.
Ajouter à votre liste de souhaits iMusic

Biomarkers in Risk Assessment: Validity and Validation (Environmental Health Criteria Series)

This publication seeks to provide a framework for selecting and validating biomarkers for risk assessment. Initial chapters consider the role of biomarkers in risk assessment and their validity. A biomarker is any substance, structure or process that can be measured in the body or its products, and influence or predict the incidence of outcome or disease. Biomarkers can be classified into markers of exposure, effect and susceptibility. If biomarkers are to contribute to environmental and occupational health risk assessments, they have to be relevant and valid. Relevance refers to the appropriateness of biomarkers to provide information on questions of interest and importance to public and environmental health authorities and other decision-makers.

The validity of a biomarker is a function of intrinsic qualities of the biomarker and characteristics of the analytic procedures. Additionally, three broad categories of validity can be distinguished: measurement validity, internal study validity and external validity. Measurement validity is the degree to which a biomarker indicates what it purports to indicate. Internal study validity is the degree to which inferences drawn from a study actually pertain to study subjects and are true. External validity is the extent to which findings of a study can be generalized to apply to other populations.

Subsequent chapters examine the validation of specific types of biomarkers and cross-species comparability.

Supporting the main text are four extensive appendices covering the following subjects:
1. Biomarkers of exposure and effect for carcinogenicity
2. Biomarkers of exposure and effect for non-carcinogenic end-points
3. Measurement of drug metabolizing enzyme polymorphisms as indicators of susceptibility
4. Validation of biomarkers for environmental health research and risk assessment

Médias Livres     Paperback Book   (Livre avec couverture souple et dos collé)
Validé 2001
ISBN13 9789241572224
Éditeurs World Health Organization
Pages 238
Dimensions 150 × 14 × 225 mm   ·   344 g
Langue et grammaire English  

Afficher tout

Plus par Ipcs

Voir tous les Ipcs ( par ex. Paperback Book )